Markers of bone turnover in bone metastases (Q33970497)

30 July 2017

1 reference

title

Markers of bone turnover in bone metastases (English)

1 reference

30 July 2017

Fontana A

1

1 reference

30 July 2017

Delmas PD

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

88

1 reference

30 July 2017

issue

12 Suppl

1 reference

30 July 2017

page(s)

2952-2960

1 reference

Bone resorption induced by a metastatic human melanoma cell line

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

The biosynthesis of collagen and its disorders (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Immunoassay for urinary pyridinoline: the new marker of bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Biosynthesis of bone sialoprotein by a human osteoclast-like cell line (FLG 29.1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Pyridinium crosslinks as markers of bone resorption in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Expression of bone sialoprotein in primary human breast cancer is associated with poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

The diagnostic and prognostic value of serum bone Gla protein (osteocalcin) in patients with recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

Monitoring the action of clodronate with type I collagen metabolites in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2952%3A%3AAID-CNCR11%3E3.0.CO%3B2-M

10.1002/1097-0142(20000615)88:12+<2952::AID-CNCR11>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference